Implications for Asthma Treatment Strategies in Managed Care
Comparative Effectiveness of Early Natalizumab Treatment in JC Virus-Negative Relapsing-Remitting Multiple Sclerosis
We estimated the long-term risks and benefits of disease modifying therapies. Benefits were favored by natalizumab with minimal increased risks in the negative anti-JC virus population.
Increasing Pharmaceutical Copayments: Impact on Asthma Medication Utilization and Outcomes
Even small changes in average copayment for long-term controller asthma medications can result in significant reductions in medication use and increases in healthcare services.
Managed Care Opportunities for Improving Asthma Care
2 Clarke Drive Cranbury, NJ 08512